OT-101

OT-101 · Oncotelic Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OT-101, covering 2023-08-08 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer [Phase 2, Phase 3]

See pricing